107 results
Page 2 of 6
DEFA14A
zzhx7htr4s6fzlq nca
10 May 21
Additional proxy soliciting materials
4:18pm
DEFA14A
lf65l1eyfqfo dbgl
8 Apr 21
Additional proxy soliciting materials
4:07pm
DEFA14A
d75au206
15 Mar 21
Additional proxy soliciting materials
5:14pm
8-K
6r3fmw62i02xo
15 Mar 21
Other Events
5:11pm
8-K
EX-99.1
8v4cv63k8m0laed
25 Feb 21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
DEFM14A
wbl9uffhqee9ts4h9z
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
ph6ol5
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-99.1
q257 uizzn
29 Jan 21
Index to Consolidated Financial Statements
4:08pm
DEFA14A
vvtxle01k29q7 7y
12 Jan 21
Additional proxy soliciting materials
5:15pm
DEFA14A
mevzhlqw
11 Jan 21
Additional proxy soliciting materials
7:17am
8-K
EX-99.1
0b59sy0f1zb
11 Jan 21
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
7:14am
DEFA14A
o4hbywazl
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
EX-2.1
pij 5mla7firfj03
21 Dec 20
Additional proxy soliciting materials
9:17pm
8-K
EX-2.1
fbll2s2304e
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
DEFA14A
cnt127sdb44nb5
21 Dec 20
Additional proxy soliciting materials
5:23pm